Out of the 103 patients, statistically significant expression of NF-κB was observed in patients with AML, with FLT-ITD (26- to 29-fold, 8 patients), del 5 (~15-fold, 6 patients), and del 7 (~20-fold, 4 patients) mutations. Here, NFKB1 is linked to acute myeloid leukemia.